Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone
Background: This study investigated the value of adding Ismigen ® , a polyvalent mechanical bacterial lysate, to therapy of COPD patients (FEV 1 <60% predicted) under regular treatment with salmeterol/fluticasone (SFC). Methods: 63 patients enrolled from September to December 2007 were randomly d...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-04-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465809104677 |